Novo Nordisk shares fell after investors said Chief Executive Officer Mike Doustdar did not provide concrete turnaround plans, according to Bloomberg. The company said it plans to launch more than five blockbusters and generate more than $23 billion in new sales in coming years after losing its lead in the obesity market to Eli Lilly & Co.

Arhaus rose after Jefferies upgraded the furniture retailer to buy from hold, citing “newfound optimism” on its strategy to lift brand awareness and market share. Accenture gained after Anthropic said it is partnering with the consulting firm to test the safety of its advanced artificial intelligence models by embedding Accenture evaluators within its operations.